Of these, 107 were in the Semaglutide group and 113 in the non-Semaglutide group, with residual gastric content found in 43 of 107 patients (40%) taking Semaglutide vs
A quick search on social media using hashtags like #reta or #retatrutide pulls up countless posts from people touting benefits like rapid fat loss, more energy, improved mood, and better overall health
Treatment and results may uh, vary based on circumstances, situation, and medical judgment
The on-label and off-label use of GLP1RAs has gained popularity, driven by robust clinical research, documented benefits, and widely circulated claims on social media [1]
Colorectal cancer is being diagnosed in a growing number of young people
Data Sources: We searched PubMed and Google Scholar for evidence on GLP-1 RAs and coronary events